Health News Roundup: U.S. FDA approves bluebird bio’s gene therapy for a rare neurological disorder; Brazil approves Pfizer vaccine for children as young as six months and more

Health News Roundup: U.S. FDA approves bluebird bio’s gene therapy for a rare neurological disorder; Brazil approves Pfizer vaccine for children as young as six months and more

Following is a abstract of present well being information briefs.
Brazil approves Pfizer vaccine for children as young as six months
Brazilian nationwide well being regulator Anvisa has permitted the COVID-19 vaccine produced by Pfizer and BioNTech for children aged between six months and 4 years, the federal government physique stated in a assertion Friday evening. The transfer broadens the supply of the vaccine, which is bought underneath the model identify Comirnaty for adults and is already out there in Brazil for older age teams.
U.S. FDA approves bluebird bio’s gene therapy for a rare neurological dysfunction
The U.S. Food and Drug Administration (FDA) has permitted Bluebird bio’s gene therapy for the remedy of a rare neurological dysfunction, the corporate stated late on Friday. “SKYSONA is the primary FDA permitted therapy proven to sluggish the development of neurologic dysfunction in boys” with early, energetic Cerebral Adrenoleukodystrophy (CALD), the corporate stated in a assertion, saying CALD is a “devastating and deadly neurodegenerative illness.”
Teva Pharm expects to begin paying U.S. opioid settlement in 2023
Teva Pharmaceutical Industries expects to finalise an opioid settlement within the United States by year-end and begin paying in 2023, its chief government stated on Sunday, whereas confirming he was unlikely to resume his contract subsequent yr. After years of negotiations, Israel-based Teva in July proposed a $4.35 billion nationwide settlement – principally money and partly medicines that can quantity to $300 million to $400 million over 13 years – to resolve its opioid lawsuits.
Don’t contact foreigners to cut back monkeypox danger, says senior Chinese well being official
A senior Chinese well being official suggested individuals to keep away from bodily contact with foreigners to forestall doable monkeypox an infection after the primary recognized case of the virus on mainland China was reported on Friday. “To stop doable monkeypox an infection and as a part of our wholesome way of life, it’s endorsed that 1) you wouldn’t have direct skin-to-skin contact with foreigners,” Wu Zunyou, chief epidemiologist on the China Center for Disease Control and Prevention posted on his official Weibo web page on Saturday. (With inputs from businesses.)

https://www.devdiscourse.com/article/health/2183346-reuters-health-news-summary

Recommended For You